glp 1 and bulimia Patients with eating disorders are seeking — getting — GLP-1s GLP-1 access a problem for

Emerging research suggests the human gut microbiome may play a role in producing molybdenum cofactors, especially from dietary sources

For an unlicensed investigational compound such as retatrutide, no such validated stability data exist

It is currently in Phase 3 clinical trials and is not yet approved as a medicine in any major jurisdiction

It blocks sodium-glucose cotransporter 2, or SGLT2, a transporter that normally pulls filtered glucose back into the bloodstream

Most people can take them together safely, but it requires careful monitoring of hydration and potassium levels by a licensed healthcare professional